Lataa...
Acute liver failure after changing oral anticoagulant from apixaban to rivaroxaban
Rivaroxaban is a commonly used anticoagulant agent for treatment and prevention of thromboembolism. There are case reports demonstrating an association between its use and drug-induced liver injury. However, this has not been reported in a patient who previously tolerated apixaban. An 88-year-old ma...
Tallennettuna:
| Julkaisussa: | BMJ Case Rep |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094353/ https://ncbi.nlm.nih.gov/pubmed/33910797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-240719 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|